DOD Amyotrophic Lateral Sclerosis Research Program (ALSRP) LOI
Well-being, Health and Biomedical Discovery
Deadlines
Academic Unit: inquire with unit
Memorial Deadline: RIS Review not required for LOI
External Deadline: Tuesday 18th, June 2024
Description
- New Deadline for ALSRP Letters of Intent – June 18, 2024 at 5:00 pm Eastern time
- The Amyotrophic Lateral Sclerosis Research Program (ALSRP) released program announcements for the following funding opportunities:
- – Clinical Outcomes and Biomarkers Award
- – Pilot Clinical Trial Award
- – Therapeutic Development Award
- – Therapeutic Idea Award
A pre-application is required and must be submitted through the electronic Biomedical Research Application Portal (eBRAP) at https://eBRAP.org prior to the pre-application deadline.
All applications must conform to the final Funding Opportunities/Program Announcements and General Application Instructions which can be found on the Grants.gov website (https://Grants.gov). A listing of all CDMRP and other USAMRDC extramural funding opportunities can be obtained on the Grants.gov website by performing a basic search using CFDA Number 12.420. Applicant organizations must be registered in SAM (https://www.sam.gov/SAM/) and receive confirmation of an “Active” status before submitting an application through Grants.gov.
Pre-Application: (Letter of Intent): May 24, 2024 5:00 p.m. Eastern time
New Deadline for ALSRP Letters of Intent – June 18, 2024 at 5:00 pm Eastern time
Application: July 10, 2024 11:59 p.m. Eastern Time
See here for more information.